Related Experiment Video
Updated: Apr 29, 2026
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
[Langerhans cell histiocytosis]
J Rojo Álvaro1, S Pérez Ricarte, M Alfonso Imízcoz
1Servicio de Medicina Interna, Complejo Hospitalario de Navarra, Pamplona, 31008, Spain. jorgerojo23@hotmail.com.
Insights
This case study discusses Langerhans cell histiocytosis, a rare interstitial lung disease. Diagnosis involves bronchoalveolar lavage or biopsy, with smoking cessation being the primary treatment for potential favorable outcomes.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Langerhans cell histiocytosis (LCH), also known as Histiocytosis X, is a rare interstitial lung disease.
- Its exact incidence and prevalence remain largely unknown.
- Clinical suspicion arises from epidemiological and radiological findings.
Abstract:
We describe the case of male diagnosed with histiocytosis of Langerhans cells. Histiocytosis X is an interstitial disease with a real incidence and an unknown prevalence that can be suspected due to epidemiological and radiological data. The diagnosis can be realized using BAL and/or anatomo-pathological study of a biopsy. The principal treatment is to give up the tobacco habit. Evolution can be favourable.
